Relmada Therapeutics (RLMD) Receives U.S. Patent Related to REL-1017
Tweet Send to a Friend
Relmada Therapeutics, Inc. (OTC: RLMD) announced that the U.S. Patent and Trademark Office has issued U.S. Patent 9,468,611 for "d-Methadone ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
